DCM
VTRS icon

DME Capital Management’s Viatris VTRS Stock Holding History

DME Capital Management’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44M Buy
2,773,470
+955,900
+53% +$14.8M 1.13% 33
2026
Q1 		$24.6M Buy
+1,817,570
New +$25.4M 0.77% 34
2025
Q2 		– Sell
-6,000,830
Closed -$52.3M – 37
2025
Q1 		$52.3M Buy
6,000,830
+215,720
+4% +$2.26M 2.65% 13
2024
Q4 		$72M Sell
5,785,110
-1,485,320
-20% -$18.3M 3.7% 8
2024
Q3 		$84.4M Sell
7,270,430
-129,380
-2% -$1.49M 3.51% 9
2024
Q2 		$78.7M Buy
7,399,810
+2,882,190
+64% +$31.8M 3.85% 10
2024
Q1 		$53.9M Buy
+4,517,620
New +$54.4M 2.47% 11

Other funds holding VTRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DME Capital Management's VTRS Position: Q2 2026 in Review

DME Capital Management increased its Viatris (VTRS) stake by 53% in Q2 2026, buying an estimated $14.8M and bringing the position to 2,773,470 shares worth $44M. The position accounts for 1.13% of the portfolio, ranked #33.

DME Capital Management first reported a position in VTRS in Q1 2024 and has held it in 7 quarters since. The position peaked at $84.4M in Q3 2024. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • DME Capital Management held 2,773,470 shares of Viatris worth $44M as of Q2 2026.
  • DME Capital Management bought 955,900 Viatris shares in Q2 2026, an estimated $14.8M.
  • Viatris made up 1.13% of DME Capital Management's portfolio in Q2 2026, its #33 holding.
  • DME Capital Management first reported a position in Viatris in Q1 2024 and has held it in 7 quarters since.
  • DME Capital Management's Viatris position peaked at $84.4M in Q3 2024.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on DME Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.